Equities research analysts expect that Orthopediatrics Corp (NASDAQ:KIDS) will announce earnings of ($0.22) per share for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Orthopediatrics’ earnings. The highest EPS estimate is ($0.18) and the lowest is ($0.27). Orthopediatrics reported earnings per share of ($0.19) in the same quarter last year, which suggests a negative year-over-year growth rate of 15.8%. The firm is scheduled to issue its next quarterly earnings report on Wednesday, March 4th.
On average, analysts expect that Orthopediatrics will report full year earnings of ($0.82) per share for the current year, with EPS estimates ranging from ($0.88) to ($0.76). For the next year, analysts expect that the business will report earnings of ($0.35) per share, with EPS estimates ranging from ($0.55) to ($0.15). Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for Orthopediatrics.
Orthopediatrics (NASDAQ:KIDS) last announced its earnings results on Thursday, November 7th. The company reported ($0.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.01). Orthopediatrics had a negative return on equity of 12.22% and a negative net margin of 15.80%. The business had revenue of $20.74 million during the quarter, compared to analysts’ expectations of $19.87 million. During the same quarter in the previous year, the firm earned ($0.15) EPS. Orthopediatrics’s quarterly revenue was up 31.1% on a year-over-year basis.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA increased its stake in Orthopediatrics by 62.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 671,588 shares of the company’s stock valued at $23,680,000 after buying an additional 258,146 shares during the period. Riverbridge Partners LLC boosted its position in shares of Orthopediatrics by 41.3% in the 3rd quarter. Riverbridge Partners LLC now owns 513,070 shares of the company’s stock worth $18,091,000 after buying an additional 149,855 shares in the last quarter. Roubaix Capital LLC purchased a new stake in shares of Orthopediatrics in the 2nd quarter worth about $3,497,000. BlackRock Inc. boosted its position in shares of Orthopediatrics by 16.8% in the 2nd quarter. BlackRock Inc. now owns 585,555 shares of the company’s stock worth $22,837,000 after buying an additional 84,205 shares in the last quarter. Finally, Wasatch Advisors Inc. boosted its position in shares of Orthopediatrics by 28.2% in the 2nd quarter. Wasatch Advisors Inc. now owns 347,598 shares of the company’s stock worth $13,556,000 after buying an additional 76,534 shares in the last quarter. Hedge funds and other institutional investors own 50.42% of the company’s stock.
Shares of NASDAQ KIDS traded up $0.57 during midday trading on Tuesday, reaching $38.07. The company’s stock had a trading volume of 3,028 shares, compared to its average volume of 53,956. Orthopediatrics has a 12-month low of $25.11 and a 12-month high of $47.82. The firm has a 50 day moving average price of $36.27 and a 200-day moving average price of $36.99. The stock has a market capitalization of $560.23 million, a P/E ratio of -39.66 and a beta of 0.23. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.53 and a quick ratio of 1.75.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Featured Article: Gap Down Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.